Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Oct 12, 2023 8:11pm
75 Views
Post# 35681502

RE:RE:Next week at this time…

RE:RE:Next week at this time… Apologies for all the typos in the last post (too hasty).  I have re-posted it here:

Yes JC wishful thinking but we are all doing it. Our imagination runs away with us as we speculate what could happen to the share price if Replicel wins this Arbitration then reality sets in.  We could see all of our investments vanish for the most part if the Arbitrator rules against Replicel.

I get the feeling that Shiseido has not been a perfect participant in this Arbitration.  To the contrary I think part of the problem (and this is only speculation) in this Arbitration is Shiseido's feet dragging. I think in order for a positive result from this Arbitration Replicel has done everything that has been asked of them in a timely manner.  I am not sure if that has been the case for Shiseido.

Regardless we have to hope the end of this nonsense is near and we can move on from this and put our energy into something more meaninful.

Good luck to all the longs.
<< Previous
Bullboard Posts
Next >>